Literature DB >> 7006783

Regional program for the study of glomerulonephritis. Central Committee of the Toronto Glomerulonephritis Registry.

.   

Abstract

The Toronto Glomerulonephritis Registry, a regional program for studying the natural history of the different types of glomerulonephritis and the effects of drug therapy on them, was established 6 years ago in Toronto. Data for all patients with histologic evidence of glomerulonephritis seen at the 16 participating hospitals are collected on standard forms and stored in a computer. Randomized controlled trials of different types of therapy for five types of glomerulonephritis have been started under the coordination of the central registry. In view of the registry's low cost and high potential benefit, greater support for such projects is needed. Other centres should consider establishing similar registries to promote more rapid collection of cases and thus allow better evaluation of the development and treatment of this major cause of renal failure.

Entities:  

Mesh:

Year:  1981        PMID: 7006783      PMCID: PMC1705155     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  3 in total

1.  The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials.

Authors:  J A Freiman; T C Chalmers; H Smith; R R Kuebler
Journal:  N Engl J Med       Date:  1978-09-28       Impact factor: 91.245

2.  Cyclophosphamide in lupus nephritis: a controlled trial.

Authors:  A D Steinberg; H B Kaltreider; P J Staples; E J Goetzl; N Talal; J L Decker
Journal:  Ann Intern Med       Date:  1971-08       Impact factor: 25.391

3.  Immunosuppressive therapy in adults with proliferative glomerulonephritis. Controlled trial.

Authors:  L J Booth; G M Aber
Journal:  Lancet       Date:  1970-11-14       Impact factor: 79.321

  3 in total
  6 in total

1.  Demographic and clinical characteristics of primary glomerular diseases in Turkey.

Authors:  Savas Ozturk; Abdullah Sumnu; Nurhan Seyahi; Mustafa Gullulu; Murat Sipahioglu; Serra Artan; Zerrin Bicik; Sim Kutlay; Mustafa Keles; Deren Oygar; Ali Riza Odabas; Mansur Kayatas; Belda Dursun; Hayriye Sayarlioglu; Sinan Trablus; Dilek Guven Taymez; Ali Abbas Ozdemir; Gulizar Manga Sahin; Bulent Altun; Alper Azak; Lutfullah Altintepe; Gultekin Suleymanlar; Mehmet Koc; Yilmaz Selcuk; Rumeyza Kazancioglu; Reha Erkoc; Meltem Gursu; Mehmet Kucuk; Selma Alagoz Akcaoglu; Abdulmecid Yıldız; Aydin Unal; Ozger Akarsu; Kenan Ates; Erdem Cankaya; Aydin Turkmen
Journal:  Int Urol Nephrol       Date:  2014-09-30       Impact factor: 2.370

2.  Non-diabetic urine glucose in idiopathic membranous nephropathy.

Authors:  Lingling Liu; Ke Zuo; Weibo Le; Manman Lu; Zhihong Liu; Weiwei Xu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

3.  The Canadian Glomerulonephritis Registry (CGNR) and Translational Research Initiative: Rationale and Clinical Research Protocol.

Authors:  Ainslie M Hildebrand; Moumita Barua; Sean J Barbour; Karthik K Tennankore; Daniel C Cattran; Tomoko Takano; Ping Lam; Sacha A De Serres; Ratna Samanta; Michelle A Hladunewich; Todd Fairhead; Penelope Poyah; D Danielle Bush; Brian MacLaren; Dwight Sparkes; Philip Boll; Arenn Jauhal; Rohan John; Carmen Avila-Casado; Heather N Reich
Journal:  Can J Kidney Health Dis       Date:  2022-04-08

4.  Membranous Nephropathy: Quantifying Remission Duration on Outcome.

Authors:  Daniel C Cattran; Esther D Kim; Heather Reich; Michelle Hladunewich; S Joseph Kim
Journal:  J Am Soc Nephrol       Date:  2016-10-18       Impact factor: 10.121

5.  An overview of the British Columbia Glomerulonephritis network and registry: integrating knowledge generation and translation within a single framework.

Authors:  Sean Barbour; Monica Beaulieu; Jagbir Gill; Ognjenka Djurdjev; Heather Reich; Adeera Levin
Journal:  BMC Nephrol       Date:  2013-10-29       Impact factor: 2.388

Review 6.  Challenges in primary focal segmental glomerulosclerosis diagnosis: from the diagnostic algorithm to novel biomarkers.

Authors:  Conxita Jacobs-Cachá; Ander Vergara; Clara García-Carro; Irene Agraz; Nestor Toapanta-Gaibor; Gema Ariceta; Francesc Moreso; Daniel Serón; Joan López-Hellín; Maria José Soler
Journal:  Clin Kidney J       Date:  2020-08-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.